1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
(
- Contribution to journal › Article
-
Mark
C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
(
- Contribution to journal › Article
-
Mark
Potential subtype-specific therapeutic approaches in small cell lung cancer
(
- Contribution to journal › Scientific review
-
Mark
Small cells – big issues : biological implications and preclinical advancements in small cell lung cancer
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
(
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
(
- Contribution to journal › Article
-
Mark
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair
2023) In Clinical cancer research : an official journal of the American Association for Cancer Research 29(22). p.4644-4659(
- Contribution to journal › Article
-
Mark
Unfolding the secrets of small cell lung cancer progression : Novel approaches and insights through rapid autopsies
(
- Contribution to journal › Debate/Note/Editorial